Victory Capital Management Inc. Purchases 39,942 Shares of The Clorox Company (NYSE:CLX)

Victory Capital Management Inc. boosted its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 12.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 363,554 shares of the company's stock after purchasing an additional 39,942 shares during the period. Victory Capital Management Inc. owned about 0.29% of Clorox worth $59,045,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of CLX. Los Angeles Capital Management LLC boosted its stake in shares of Clorox by 5.6% in the 3rd quarter. Los Angeles Capital Management LLC now owns 191,919 shares of the company's stock valued at $31,266,000 after purchasing an additional 10,149 shares in the last quarter. Advisors Asset Management Inc. boosted its position in Clorox by 43.4% in the third quarter. Advisors Asset Management Inc. now owns 29,865 shares of the company's stock valued at $4,865,000 after buying an additional 9,037 shares in the last quarter. Natixis Advisors LLC grew its stake in shares of Clorox by 8.3% during the third quarter. Natixis Advisors LLC now owns 63,476 shares of the company's stock worth $10,341,000 after buying an additional 4,839 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Clorox by 1.8% during the third quarter. Charles Schwab Investment Management Inc. now owns 723,906 shares of the company's stock worth $117,932,000 after buying an additional 13,038 shares in the last quarter. Finally, Public Employees Retirement System of Ohio increased its holdings in shares of Clorox by 26.3% during the third quarter. Public Employees Retirement System of Ohio now owns 59,766 shares of the company's stock worth $9,736,000 after buying an additional 12,428 shares in the last quarter. Institutional investors own 78.53% of the company's stock.

Remove Ads

Clorox Stock Performance

Clorox stock traded up $0.69 during mid-day trading on Monday, reaching $151.72. 205,426 shares of the company's stock were exchanged, compared to its average volume of 1,203,851. The firm has a market capitalization of $18.69 billion, a PE ratio of 41.38, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The business's fifty day simple moving average is $155.65 and its 200 day simple moving average is $160.47. The Clorox Company has a one year low of $127.60 and a one year high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the business posted $2.16 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.22%. The ex-dividend date is Wednesday, April 23rd. Clorox's dividend payout ratio is currently 133.33%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. JPMorgan Chase & Co. boosted their price objective on Clorox from $171.00 to $173.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Evercore ISI boosted their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Wells Fargo & Company boosted their target price on shares of Clorox from $157.00 to $161.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. StockNews.com downgraded shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Finally, Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.